Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy

被引:70
作者
Williams, Sian A. [1 ]
Reid, Siobhan [1 ]
Elliott, Catherine [2 ]
Shipman, Peter [3 ]
Valentine, Jane [4 ]
机构
[1] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia
[2] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[3] Princess Margaret Hosp, Dept Diagnost Imaging, Perth, WA, Australia
[4] Princess Margaret Hosp, Dept Paediat Rehabil, Perth, WA, Australia
关键词
SKELETAL-MUSCLE; ADVERSE EVENTS; GASTROCNEMIUS-MUSCLE; LOWER-EXTREMITY; INJECTION; MORPHOLOGY; STATEMENT; EFFICACY; GROWTH; SAFETY;
D O I
10.1111/dmcn.12200
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
\AIM With evidence for an atrophic effect of botulinum toxin type A (BoNT-A) documented in typically developing muscles, this study investigated the immediate morphological alterations of muscles in children with cerebral palsy (CP) after BoNT-A treatment. METHOD Fifteen children (10 males, five females; age range 5-11y, mean age 8y 5mo, SD 1y 10mo) with spastic diplegic CP [Gross Motor Function Classification System Levels I (n=9) and II (n=6)] receiving BoNT-A injections for spasticity management were included. None of the children was a first-time receiver of BoNT-A. Magnetic resonance imaging and Mimics software assessed muscle volume, timed 2 weeks before and 5 weeks after injection. All participants received BoNT-A bilaterally to the gastrocnemius muscle, and five participants also received BoNT-A bilaterally to the medial hamstring muscles. Functional assessment measures used were the 6-Minute Walk Test (6-MWT), the Timed Up and Go (TUG) test, and hand-held dynamometry. RESULTS Whilst total muscle group volume of the injected muscle group remained unchanged, a 4.47% decrease in the injected gastrocnemius muscle volume (p=0.01) and a 3.96% increase in soleus muscle volume (p=0.02) was evident following BoNT-A. There were no statistically significant changes in function after BoNT-A as assessed by the TUG. There was also no statistically significant change in distance covered in the 6-MWT. Muscle strength, as assessed using hand-held dynamometry was also not statistically different after BoNT-A treatment. INTERPRETATION Muscle volume decreases were observed in the injected muscle (gastrocnemius), with synergistic muscle hypertrophy that appeared to compensate for this decrement. The 4% to 5% decrease in the volume of BoNT-A injected muscles are not dramatic in comparison to reports in recent animal studies, and are a positive indication for BoNT-A, particularly as it also did not negatively alter function.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 30 条
[21]   Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement [J].
Love, S. C. ;
Novak, I. ;
Kentish, M. ;
Desloovere, K. ;
Heinen, F. ;
Molenaers, G. ;
O'Flaherty, S. ;
Graham, H. K. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 :9-37
[22]   Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection - An animal model study. [J].
Ma, J ;
Elsaidi, GA ;
Smith, TL ;
Walker, FO ;
Tan, KH ;
Martin, E ;
Koman, LA ;
Paterson, SB .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2004, 83 (10) :774-780
[23]   'Adverse events following repeated injection with botulinum toxin A in children with spasticity' [J].
Mohamed, KA ;
Morre, AP ;
Rosenbloom, L .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (11) :791-791
[24]   Safety and efficacy of botulinum toxin type A following long-term use [J].
Naumann, M. ;
Albanese, A. ;
Heinen, F. ;
Molenaers, G. ;
Relja, M. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 :35-40
[25]   Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy [J].
O'Flaherty, Stephen J. ;
Janakan, Vyshnavi ;
Morrow, Angela M. ;
Scheinberg, Adam M. ;
Waugh, Mary-Clare A. .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (02) :125-130
[26]   Childhood muscle morphology and strength: Alterations over six months of growth [J].
Pitcher, Christian A. ;
Elliott, Catherine M. ;
Williams, Sian A. ;
Licari, Melissa K. ;
Kuenzel, Alex ;
Shipman, Peter J. ;
Valentine, Jane P. ;
Reid, Siobhan L. .
MUSCLE & NERVE, 2012, 46 (03) :360-366
[27]   Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers [J].
Schroeder, A. Sebastian ;
Ertl-Wagner, Birgit ;
Britsch, Stefanie ;
Schroeder, J. Michael ;
Nikolin, Stefan ;
Weis, Joachim ;
Mueller-Felber, Wolfgang ;
Koerte, Inga ;
Stehr, Maximilian ;
Berweek, Steffen ;
Borggraefe, Ingo ;
Heinen, Florian .
MOVEMENT DISORDERS, 2009, 24 (10) :1494-1503
[28]   The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling [J].
Steenbeek, D ;
Meester-Delver, A ;
Becher, JG ;
Lankhorst, GJ .
CLINICAL REHABILITATION, 2005, 19 (03) :274-282
[29]   Investigation of the timed 'up & go' test in children [J].
Williams, EN ;
Carroll, SG ;
Reddihough, DS ;
Phillips, BA ;
Galea, MP .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2005, 47 (08) :518-524
[30]   Botox produces functional weakness in non-injected muscles adjacent to the target muscle [J].
Yaraskavitch, M. ;
Leonard, T. ;
Herzog, Walter .
JOURNAL OF BIOMECHANICS, 2008, 41 (04) :897-902